BCRX   $8.0  6.38% Market Open

BioCryst Pharmaceuticals Inc
Total Cash 272.03M
totalCashPerShare 1.315
EBITDA -52.71M
Total Debt 850.64M
quickRatio 2.64
currentRatio 2.816
Total Revenue 382.24M
debtToEquity
Revenue/Share 1.902
ROA -0.06908
ROE
grossProfits
freeCashflow -26.13M
operatingCashflow -83.87M
earningsGrowth
revenueGrowth 0.325
grossMargins 0.47055998
ebitdaMargins -0.1379
operatingMargins 0.080129996
profitMargins -0.38179
enterpriseValue 2.13B
forwardPE -47.0
floatShares 192.41M
sharesOutstanding 206.89M
sharesShort 23.23M
sharesShortPriorMonth 24.06M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.87%
Short Ratio help_outline 12.78%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue -2.302
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -145.93M
trailingEps -0.73%
forwardEps -0.16%
enterpriseToEbitda -40.49
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.06 3Q 2024
institutionsCount 326
lastUpdated Oct. 22, 2024, 3:23 a.m.